Table 1.
Age (Days) | ||||
---|---|---|---|---|
20/30 | 40 | 60 | 80 | |
Capacitance | N | √ | ||
Input resistance | √ | √ | ||
EPSC frequency | √ | √ | ||
EPSC-BIC frequency | √ | √ | ||
IPSC frequency | N | N | ||
Proportion of cells with high frequency IPSCs | √ | √ | ||
NMDA peak current (Mg2+-free) | N | N | N | |
NMDA current density (Mg2+-free) | N | √ | N | |
NMDA peak current (50 μM Mg2+) | √ | √ | N | |
NMDA current density (50 μM Mg2+) | √ | √ | N | |
NMDA 50 μM Mg2+ % baseline | √ | √ | √ | |
Body weight | N | N | N | √ |
Hind-limb clasping | N | N | N | N |
rotarod | N | √ | √ | √ |
Pole test | N | N | N | N |
Seizure susceptibility | √ | |||
Diffuse nuclear staining | N | N | √ | |
Nuclear microaggregates | N | N | √ | |
Neuronal intranuclear inclusions | N | √ | √ | |
Neuropil aggregates | N | N | N |
√ indicates that an inverted U-shaped function was displayed. N indicates that an inverted U-shaped function was not displayed. Blank indicates the measure was not, or could not be, assessed. EPSC, excitatory postsynaptic current; BIC, bicuculline methobromide; IPSC, inhibitory postsynaptic current; NMDA, N-methyl-d-aspartate.